Evidence Based Medicine

The Long-CO (Long School of Medicine COVID-19 Medical Student Response Team) Evidence-based Medicine Team is composed of medical students and faculty advisors. The medical students formed four sub teams: Epidemiology, Diagnostics, Clinical Presentation, and Treatment to review current literature and create executive summaries and information sheets summarizing the literature for use by clinicians throughout the COVID-19 pandemic.

• General population
• Marginalized population
• Medically at-risk population
• Masks
• Transmission

Medical Students: Jane Anderson (MS3), Chase Ballard (MS3), Olivia Chen (MS2), Laureen Gbordzoe (MS2) - Current Student Leader, Dr. Rose Ann Huynh (Alumni), Chloe Jensen (MS2), Swetha Maddipudi (MS3), Salil Ojha (MS4

Faculty Advisor: Jason Rosenfeld, DrPH, MPH, Assistant Director of Global Health, Center for Medical Humanities & Ethics and Assistant Professor of Medicine-Research and Kelly Echevarria, PharmD, National Clinical Pharmacy Program Manager, Audie Murphy VA

Resources Developed:

• SARS-CoV 2 Epidemiology Executive Summary – September 21, 2020
• SARS-CoV 2 Impact on Health Systems Executive Summary – September 21, 2020
• Information sheets with references:
  • African American Population
  • City Strategies and Plans
  • Elderly Population
  • Extending Usability of N95s
  • Indirect Effects
  • LatinX Population
  • LGBTQ+ Population
  • Male Population
  • Mask Wearing by the Public
  • Pediatric Population
  • Stay at Home Orders Effectiveness
  • Transmission in Droplet vs Aerosolized Form
  • Transmission from Objects
  • Vertical Transmission

Past Executive Summaries:

• SARS-CoV 2 Epidemiology - Populations Executive Summary - May 18, 2020
• SARS-CoV 2 Epidemiology - Impact on Health Systems Executive Summary - May 18, 2020
• SARS-CoV 2 Epidemiology - Populations Executive Summary - June 1, 2020
• SARS-CoV 2 Epidemiology - Impact on Health Systems Executive Summary - June 1, 2020
• SARS-CoV 2 Epidemiology - Populations Executive Summary - June 29, 2020
• SARS-CoV 2 Epidemiology - Impact on Health Systems Executive Summary - June 29, 2020
• SARS-CoV 2 Epidemiology - Populations Executive Summary – July 27, 2020
• SARS-CoV 2 Epidemiology - Impact on Health Systems Executive Summary - July 27, 2020
• SARS-CoV 2 Epidemiology Executive Summary – August 24, 2020
• SARS-CoV 2 Impact on Health Systems Executive Summary – August 24, 2020

• Who to test
• PCR
• Serology
• Status of Texas & US Testing
• Key populations

Medical Students: Victoria Arnold (MS4), Leen Azeez (MS1), Fatima Dollar (MS4), Frank Jing (MS3), Aishwarya Kothare (MS2), Brandon Lam (MS3), Albert Lee (MS2) - Current Student Leader, Mouhamed Nashawi (MS3), Nicholas Rowley (MS4), Aditi Sharma (MS3), Cesar Trivino (MS3)

Faculty Advisor: Barbara Taylor, MD, MS, Assistant Dean of MD/MPH Program, Associate Professor of Infectious Diseases, Department of Medicine

Resources Developed:

• SARS-CoV 2 Diagnostics Executive Summary – September 21, 2020
• Evidence-Based Medicine InfoSheet: COVID-19 Diagnostics and Testing

Past Executive Summaries:

• SARS-CoV 2 Diagnostics Executive Summary – May 18, 2020
• SARS-CoV 2 Diagnostics Executive Summary – June 1, 2020
• SARS-CoV 2 Diagnostics Executive Summary – June 29, 2020
• SARS-CoV 2 Diagnostics Executive Summary – July 27, 2020
• SARS-CoV 2 Diagnostics Executive Summary – August 24, 2020

• Typical presentation
• Key groups for atypical presentation
• Risk factors for severe disease, morbidity and mortality
• Common complications

Medical Students: Dr. Kent Carter, Anisha Guda (MS3), Taylor McCracken (MS2), Noah Hodson (MS3), Cynthia Jiang (MS3), Kavina Patel (MS3), Anusha Sherwani (MS2), Keerthi Thallapureddy (MS3), Aleena Vargas (MS3) - Current Student Leader, Tracy Vuong (MS3), Salma Yazji (MS2), Caroline Zhu (MS3)

Faculty Advisor: Philip Ponce, MD, Assistant Professor of Infectious Disease, Department of Medicine and Kelly Echevarria, PharmD, National Clinical Pharmacy Program Manager, Audie Murphy VA

Resources Developed:

• SARS-CoV 2 Clinical Presentation Executive Summary - September 21, 2020
• SARS-CoV 2 Clinical Presenation - Pediatric Executive Summary - September 21, 2020
• Information sheet with references:
  • Evidence-Based Medicine InfoSheet: Clinical Presentation
  • Evidence-Based Medicine InfoSheet: Clinical Presentation (Pediatric)

Past Executive Summaries:

• SARS-CoV 2 Clinical Presentation Executive Summary - May 18, 2020
• SARS-CoV 2 Clinical Presentation Executive Summary - June 1, 2020
• SARS-CoV 2 Clinical Presentation Executive Summary - June 29,2020
• SARS-CoV 2 Clinical Presentation Executive Summary - July 27, 2020
• SARS-CoV 2 Clinical Presentation Executive Summary - August 24,2020
• SARS-CoV 2 Clinical Presenation - Pediatric Executive Summary - August 24, 2020

• Supportive care
• Direct-acting agents

Medical Students: Laura Berardo (MS3), Claire Harrison (MS4), Austin Gay (MS3), Elise Lasker (MS4), Shawna Mattathil (MS3), Cory Nunn (MS3), Anjali Prasad (MS2), Brian Seegmiller (MS4), Michelle Sutanto (MS2) - Current Student Leader, and Saraaga Tamirisa (MS2)

Faculty Advisors: Kristi Traugott, PharmD, BCPS, BCIDP, Clinical Pharmacy Specialist, Infectious Disease and Elizabeth Hand, PharmD, BCIDP, Clinical Pharmacy Specialist, Infectious Disease

Resources Developed:

• SARS-CoV 2 Treatment Executive Summary - September 21, 2020
• Evidence-based Medicine Infosheet: COVID-19 Treatment

Past Executive Summaries:

• SARS-CoV 2 Treatment Executive Summary - May 18, 2020
• SARS-CoV 2 Treatment Executive Summary - June 1, 2020
• SARS-CoV 2 Treatment Executive Summary - June 29, 2020
• SARS-CoV 2 Treatment Executive Summary - July 27, 2020
• SARS-CoV 2 Treatment Executive Summary - August 24, 2020